Strengths

● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 47% by 2026.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.